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Purpose: The pathogenesis of age-related macular degeneration involves impaired protein degradation in retinal pigment
epithelial (RPE) cells. The ubiquitin-proteasome pathway and the lysosomal pathway including autophagy are the major
proteolytic systems in eukaryotic cells. Prior to proteolysis, heat shock proteins (HSPs) attempt to refold stress-induced
misfolded proteins and thus prevent the accumulation of cytoplasmic protein aggregates. Recently, p62/sequestosome 1
(p62) has been shown to be a key player linking the proteasomal and lysosomal clearance systems. In the present study,
the functional roles of p62 and HSP70 were evaluated in conjunction with proteasome inhibitor–induced autophagy in
human RPE cells (ARPE-19).
Methods:  The  p62,  HSP70,  and  ubiquitin  protein  levels  and  localization  were  analyzed  by  western  blotting  and
immunofluorescense. Confocal and transmission electron microscopy were used to detect cellular organelles and to
evaluate  the  morphological  changes.  The  p62  and  HSP70  levels  were  modulated  using  RNA  interference  and
overexpression techniques. Cell viability was measured by colorimetric assay.
Results: Proteasome inhibition evoked the accumulation of perinuclear aggregates that strongly colocalized with p62 and
HSP70. The p62 perinuclear accumulation was time- and concentration-dependent after MG-132 proteasome inhibitor
loading. The silencing of p62, rather than Hsp70, evoked suppression of autophagy, when related to decreased LC3-II
levels after bafilomycin treatment. In addition, the p62 silencing decreased the ubiquitination level of the perinuclear
aggregates. Recently, we showed that hsp70 mRNA depletion increased cell death in ARPE-19 cells. Here, we demonstrate
that p62 mRNA silencing has similar effects on cellular viability.
Conclusions: Our findings open new avenues for understanding the mechanisms of proteolytic processes in retinal cells,
and could be useful in the development of novel therapies targeting p62 and HSP70.
Age-related macular degeneration (AMD) is the leading
cause  of  blindness  of  elderly  people  in  the  developed
countries. The disease affects the macula, which is located in
the central area of the retina. Primarily, AMD is characterized
by  degeneration  of  the  macular  retinal  pigment  epithelial
(RPE) cells [1]. The RPE cells take care of the health of rods
and cones. Therefore, the degeneration and cell death of RPE
cells  cause  secondary  adverse  effects  on  the  neural  cells,
ultimately leading to visual loss. Chronic oxidative stress and
inflammation are key factors evoking RPE degeneration and
promoting the AMD process [2,3]. One hallmark of AMD is
the accumulation of lysosomal lipofuscins, and extracellular
drusens  between  RPE  cells  and  Bruch’s  membrane.  This
cargo is a clear evidence of a disturbance in the cellular protein
Correspondence to: Kai Kaarniranta, Department of Ophthalmology,
University  of  Kuopio,  P.O.  Box  1627,  70211  Kuopio,  Finland;
Phone.:  +358-17-162015;  FAX:  +358-17-162048;  email:
Kai.Kaarniranta@uef.fi
clearance system in aged RPE cells [1]. Recently, it has been
documented that in human AMD donor samples and in RPE
cell cultures, there are increased levels of autophagic markers
and decreased lysosomal activity [4-7].
Eukaryotic cells have two major proteolytic systems for
the clearance of proteins: the first is the ubiquitin-proteasome
pathway and the second is the vesicle-dependent lysosomal
pathway  [8].  The  ubiquitin-proteasome  system  recognizes
and  selectively  degrades  oxidatively  damaged  soluble
proteins that have not been successfully repaired by molecular
chaperones such as heat shock proteins (HSPs) [1]. Prior to
proteolysis, these proteins are tagged with a small polypeptide
called  ubiquitin  [9,10].  It  has  been  demonstrated  that
proteasomes are suppressed in RPE cells during the aging
process  [11].  Autophagy,  which  can  be  subdivided  into
macroautophagy, microautophagy, and chaperone-mediated
autophagy, is part of the lysosomal proteolytic mechanism
[12]. The autophagy usually shares its proteolytic burden with
proteasomes during normal cellular homeostasis and protein
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1399clearance in response to cellular stress and the aging process
[1,13,14]. The lysosomes receive material for degradation
from  different  intra-  and  extracellular  mechanisms.
Quantitatively, autophagy is the major process that delivers
substrates  to  the  lysosomal  compartment  for  degradation
[15]. Recently, there has been an increased general interest in
understanding the interactions of proteasomes and autophagy
in protein clearance.
p62/sequestosome 1 (SQSTM 1) has been shown to be a
missing link combining the functions of the proteasomal and
lysosomal  clearance  systems  [16].  The  p62  is  a  scaffold
protein  with  multiple  roles  in  cell  signaling,  receptor
internalization,  and  protein  turnover.  It  is  also  known  as
ORCA, lckBP, A170, or ZIP. The p62 was first identified as
a  phosphorylation-independent  ligand  of  the  lck  Src-like
tyrosine kinase (lckBP), and independently as an oxidative-
stress upregulated protein (A170) and as a ligand of atypical
PKC (ZIP) or RIP kinase [17]. It has been reported to be
regulator of inflammation, neurogenesis, osteoclastogenesis,
adipogenesis,  and  T-cell  differentiation.  One  of  the  most
interesting functions of p62 is the regulation of transcription
factor NF-kappa-B, which is the master regulator of innate
immunity and aging [14,17-21]. The p62 protein is commonly
found  in  inclusion  bodies  containing  polyubiquitinated
protein aggregates [22]. Ubiquitinated protein aggregates are
p62 positive in several neurodegenerative diseases such as in
Parkinson, Alzheimer, and Huntington’s diseases [23-26].
Furthermore,  p62  serves  as  a  shuttling  factor  for  the
delivery of ubiquitinated substrates to the proteasome [20,
27]. It has a ubiquitin-associated domain at its C-terminus,
enabling noncovalent binding to ubiquitin or ubiquitinated
substrate proteins [20]. At first, p62 proteins are polymerized
with each other via the Phox and Bem1p (PB1) domain in the
N-terminus. Subsequently, TNF receptor associated factor 6
(TRAF6) is attached to the TRAF6 binding site of p62 with
its ubiquitin chains in restricted situations. These branched
chains (K48, K63, employing lysine, K) are then transferred
from TRAF6 to substrate proteins, which finally interact with
ubiquitin-associated domain of p62. These complexes are then
transported to proteasomal degradation, where the N-terminal
PB1 domain of p62 binds to the proteasome. Alternatively,
ubiquitinated  complexes  are  shuttled  to  lysosomes  for
autophagocytic  degradation  [17,20,21,28].  The  proposed
mechanism for the sorting of p62-ubiquitin-substrate protein
complexes to autophagic degradation is the interaction with
microtubule-associated protein 1 light chain 3 (LC3). The
specific  autophagy  effector  LC3  is  one  of  the  several
autophagy-related genes (Atgs). Subsequently, p62 interacts
directly with LC3 in the LC3 recognition sequence domain.
If there are mutations in p62 such that it lacks the LC3 binding
site, this causes the formation of inclusion bodies, similarly
as during autophagy-deficiency [21,29-31].
In this study, the regulatory role of p62 ubiquitin adaptor/
scaffold  protein  and  HSP70  molecular  chaperone  were
evaluated in proteasome inhibitor-induced macroautophagy
in human RPE cells (ARPE-19).
METHODS
Cell culture and treatments: ARPE-19 cells were obtained
from  American  Type  Culture  Collection.  The  cells  were
grown to confluency in a humidified 10% CO2 atmosphere at
37  °C  in  Dulbecco’s  Modified  Eagle  Medium:F12  (1:1;
Gibco, Invitrogen, Carlsbad, CA), including 10% inactivated
fetal  bovine  serum  (Hyclone,  Logan,  UT),  100  units/ml
penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine (all
three  from  Lonza,  Verviers,  Belgium).  For  proteasome
inhibition, the cells were exposed to 250 nM–5 µM MG-132
proteasome inhibitor (Calbiochem, San Diego, CA) for 24 h.
The lysosomes were made alkaline by the addition of 50 nM
bafilomycin A1 (Sigma-Aldrich, Steinheim, Germany).
Western blotting: For western blotting, whole cell extracts
(15–20 µg of protein) were run in 10% or 15% sodium dodecyl
sulfate PAGE (PAGE; SDS–PAGE) gels and then wet-blotted
to  nitrocellulose  membranes  (Amersham,  Pittsburgh,  PA).
The membranes were blocked for 1 h in 3% fat-free dry milk
in  0.3%  Tween-20/phosphate  buffered  saline  (0.9%  PBS;
2 mM NaH2PO4xH2O, 0.15 M NaCl, 10 mM NaH2PO4xH2O)
at room temperature (RT). Thereafter, the membranes were
incubated  for  1  h  at  RT  with  rabbit  polyclonal  ubiquitin
antibody  (cat.  no.  Z0458;  DakoCytomation,  Glostrup,
Denmark), mouse monoclonal SQSTM1 (p62) antibody (cat.
no. sc-28359; Santa Cruz Biotechnology, Santa Cruz, CA), or
rabbit polyclonal LC3 antibody (cat. no. AP1802a; Abgent,
San  Diego,  CA).  Primary  antibodies  were  diluted  (1:500,
1:2,000, or 1:250, respectively) in 0.5% BSA (BSA) in 0.3%
Tween-20/PBS.  After  washing  3X  for  10  min  with  0.3%
Tween-20/PBS, the membranes were incubated for 1 h at RT
with  horseradish  peroxidase-conjugated  antirabbit  IgG  or
antimouse IgG antibodies (GE Healthcare, Little Chalfont,
Buckinghamshire,  UK).  The  secondary  antibodies  were
diluted (for ubiquitin 1:15,000, for p62 1:25,000, and for LC3
1:5,000) in 3% fat-free dry milk in 0.3% Tween-20/PBS.
Before detection, all of the membranes were washed as before.
Protein-antibody-complexes were detected with an enhanced
chemiluminescent  assays  for  horseradish  peroxidase
(Millipore, Billerica, MA).
Immunofluorescence:  The  cells  were  fixed  with  4%
paraformaldehyde in PBS for 10 min at RT. To determine the
localization of p62 and ubiquitin, the permeabilization was
achieved with 0.2% Triton X-100 in PBS for 15 min at 4 °C.
The samples were blocked with 3% fat-free dry milk in 0.05%
Tween/TBS  for  30  min  at  RT.  The  antibodies  (rabbit
polyclonal ubiquitin 1:80 and mouse monoclonal SQSTM1
1:500, see previous chapter) were diluted in 0.05% Tween/
TBS and incubated for one hour with samples at RT. After
washing 3× for 5 min with PBS, the samples were incubated
with secondary antirabbit or antimouse (Alexa Fluor 488/
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to 1:1,000 in 2% BSA/PBS for 1 h at RT and washed as before.
Nuclei were stained in all samples by incubation with Hoechst
33258 dye (0.5 µM/ml) for 5 min at RT. Images were captured
using a Nikon Eclipse TE300 microscope equipped with a
Nikon E995 digital camera (Nikon, Tokyo, Japan).
pDsRed2-hp62  and  pEGFP-hHSP70  fusion  plasmid
construction: Human p62 (hp62, SQSTM 1; NCBI nucleotide
accession number NM_003900) cDNA (cloned in pOTB7
vector)  was  purchased  from  RZPD  (product  no.
IRAUp969A0355D6;  Deutsches  Ressourcenzentrum  für
Genomforschung  GmbH,  Berlin,  Germany).  The  open
reading  frame  (ORF)  of  hp62  was  further  amplified  with
primers 5′-ATA CTC GAG atA TGG CGT CGC TCA CC3′
and 5′-TAT AAG CTT aTC ACA ACG GCG GGG GAT G-3′
containing restriction sites for XhoI and HindIII, respectively.
The translation initiation and termination sites are shown in
boldface. The additional bases enabling in-frame cloning are
in lower case letters. The sticky ends for the amplified p62
ORFs, as well as for the multiple cloning site of the vector
pDsRed2-C1 (Clontech, Mountain View, CA), were produced
with  the  above-mentioned  restriction  endonucleases  (MBI
Fermentas, Vilnius, Lithuania). Ligated (T4 DNA Ligase,
Roche, Basel, Switzerland) DNA forming a fusion gene of
DsRed2  and  p62  was  transfected  into  competent  DH5α
Escherichia coli cells, which were prepared using the high
efficiency  transformation  protocol  of  Inoue  et  al.  [32],
cultured, and purified [33]. The integrity of the construct,
denominated hereafter as pDsRed2-hp62 (h for human) was
determined  initially  by  restriction  endonuclease  digestion
analysis and finally sequencing of the junction sites and the
entire inserted p62 ORF. Details of the GFP-HSP70 construct
(pEGFP-hHsp70) have been recently documented [13].
Studying of the p62 and HSP70 colocalization in ARPE-19
cells:  For  colocalization  studies  in  living  cells,  ARPE-19
cultures were grown on 8-well glass slides (Nunc Lab-Tek®
Chambered Borosilicate Coverglasses, cat. no. 155411; Nalge
Nunc, Rochester, NY). Before plating the cells, the glasses
were treated with collagen Type IV (50 µg/ml in 20 mM acetic
acid; Becton Dickinson, Franklin Lakes, NJ) for 1 h and rinsed
with phosphate buffer and culture medium. Cells were grown
for 24 h before the transfection of fluorescent plasmids to
achieve 50%–70% confluency. Briefly, 500 µg of plasmid,
either  pEGFP-hHSP70  or  pDsRed2-hp62,  or  both
simultaneously (250 ng each), was added to diluted ExGen
500  transfection  reagent  (MBI  Fermentas)  following  the
manufacturer’s instructions. Briefly, 500 µg of plasmid, either
pEGFP-hHSP70 or pDsRed2-hp62 or both simultaneously
(250 ng+250 ng), was added to diluted ExGen 500 non-toxic
cationic polymer-based transfection reagent (MBI Fermentas)
following the manufacturer's instructions. Transfection was
continued for 24 h in a total volume of 200 µl on each well,
and  subsequently  proteasome  inhibitor  MG-132
(Calbiochem)  was  added  to  the  cultures  at  a  5  µM
concentration for 24 h.
The  fluorescent  fusion  proteins  were  localized  with
confocal microscopy (Nikon Eclipse TE 300 microscope with
a 100× oil immersion objective; Nikon). The EGFP stain was
visualized at an excitation wavelength of 488 nm and emission
at  525  nm.  The  wavelengths  for  monitoring  DsRed2
fluorescence were 558 nm for excitation and 583 nm for
emission, and for EGFP excitation and emission wavelengths
were 488 nm and 525 nm, respectively.
Figure 1. Western blotting analysis for
evaluating  p62  RNA  interference
efficacy  and  measuring  its  effects  on
ubiquitin levels in ARPE-19 cells. Three
different p62 siRNAs were used with
three different concentrations (30, 50,
and 80 nM). The samples of p62 siRNA
were also treated with 5 µM MG-132.
Bl. stands for untreated control, tr. for
transfection reagent (with or without 5
µM MG-132), and negative siRNA for
nonsilencing siRNA (with or without 5
µM MG-132). All exposures lasted 24
h. α-Tubulin staining was used to ensure
the equal loading of proteins.
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1401Attenuation of human p62 and hsp70 gene expression by RNA
interference: To find the effective p62 siRNA, three different
siRNAs designed for human p62 gene (chosen siRNA for
further experiments was number 3 in Figure 1, cat no. s16962)
and a nonsilencing siRNA (cat. no. AM 4611) were used
(Ambion, Austin, TX). These were transfected into ARPE-19
cells using siPORT™ amine transfection reagent (Ambion)
following the manufacturer’s instructions. Reagent includes
blend  of  polyamines  formulated  for  transfection  of  small
RNAs. The tested concentrations of all p62 siRNAs in cell
cultures were 30, 50, and 80 nM (30 nM for the negative
control) and the duration of siRNA treatment was 24 h. The
decrease  in  p62  expression  was  monitored  using  western
hybridization with mouse monoclonal p62 antibody (Santa
Cruz), as described above. The silencing of the hsp70 gene
has been recently documented [13].
Transmission electron microscopy: Cell cultures treated for
24 h with the negative control, p62 (number 3 in Figure 1),
and hsp70 (cat. no. 16708; Ambion), siRNAs (concentration
of  all  three  30  nM),  and  MG-132  (5  µM;  Calbiochem),
following a recovery period of 0, 24, or 48 h were prefixed
with 2.5% glutaraldehyde and sodium phosphate buffer (0.1
M, pH 7.4) for 2 h at room temperature. After washing (15
min in phosphate buffer), samples were postfixed with 1%
osmium  tetraoxide  in  phosphate  buffer  for  1  h  and  then
washed  with  phosphate  buffer  before  normal  ethanol
dehydration. The samples were infiltrated and embedded in
LX-112 resin (Ladd Research Industries, Burlington, VT).
Figure 2. Immunofluorescence microscopy analysis of p62 (red) in ARPE-19 cells. Cells were exposed to different concentrations (250 nM–
5 µM) of MG-132 for 24 h. C stands for control. Nuclei are stained with blue dye.
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1402Figure 3. Immunofluorescence microscopy analysis of p62 (red) ARPE-19 cells. Cells were exposed to 250 nM MG-132 for different time
periods (20 min–72 h). C stands for control. Nuclei are stained with blue dye.
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1403Polymerization was performed at 37 °C for 24 h and at 60 °C
for 48 h. The sections were finally examined with a Jeol
JEM-1200EX transmission electron microscope (Jeol, Tokyo,
Japan; 80 kV).
Viability staining of cells: Cellular viability was assessed with
MTT  assay.  In  the  MTT  assay,  the  ability  of  cells  to
metabolize  the  yellow  MTT  tetrazole  salt  (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide)  to
purple formazan is measured spectrophotometrically at 570
nm [34].
Statistical analysis: The statistically significant differences
were  identified  with  SPSS  for  Windows  software  (v.  14;
SPSS, Chicago, IL) using Mann–Whitney U-test. Variations
were represented by standard deviation (n=4). p-values below
0.05 were considered significant.
RESULTS
To study the effect of different concentrations of proteasome
inhibition on p62 localization, human ARPE-19 RPE cells
were either nonstressed or exposed to 250 nm – 5 µM MG-132
for  24  h.  The  staining  of  p62  was  then  analyzed  by
immunofluorescence  microscopy.  A  clear,  concentration-
gradient-dependent increase in the intensity of p62 staining
Figure 4. Immunofluorescence microscopy analysis of p62 (red) and ubiquitin (green) in ARPE-19 cells. Cells were exposed to 5 µM MG-132
with nonsilencing siRNA or with p62 siRNA (both 30 nM) for 24 h. Nuclei are stained with blue dye. Arrows point to the colocalization of
p62 and ubiquitin in perinuclear protein aggregates.
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1404Figure 5. Analysis of perinuclear aggregates. A: Transmission electron micrographs of control ARPE-19 cells (blank), cells exposed to
transfection reagent, and cells exposed to 5 µM MG-132 for 24 h with or without transfection reagent, nonsilencing siRNA, hsp70 siRNA, or
p62 siRNA (all 30 nM). The scale bar equal to 2 μm. B: Transmission electron micrographs of the cells simultaneously treated with 5 µM
MG-132 and the transfection reagent, nonsilencing RNA, hsp70 siRNA, or p62 siRNA for 24 h, and then allowed to recover in normal cell
culture medium for 24 or 48 h. Arrows indicate autophagosomal structures.
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1405was seen in perinuclear space in response to the MG-132
treatments (Figure 2).
A constant 5 µM MG-132 exposure was used to analyze
p62 perinuclear accumulation during different time points
from 20 min to 72 h. A clearly increased p62 staining in the
perinuclear space occurred after 8 h of treatment, but an even
stronger p62 response was observed at the later time points
(Figure 3).
The efficacy of p62 siRNA was analyzed with western
blotting. The cells were either nonstressed or exposed to 5 µM
MG-132 with or without of p62 mRNA silencing for 24 h.
Western blotting analysis revealed effective blocking of the
p62 synthesis in response to the mRNA silencing when three
Figure 6. Colocalization of DsRed2-p62 and GFP-HSP70 in ARPE-19 cells, revealed by confocal microscopy analysis. Cells have been
exposed to 5 µM MG-132 for 24 h.
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1406different p62 siRNAs (siRNA 1, siRNA 2, siRNA 3) were
examined with three different concentrations (30, 50, and 80
nM).  For  further  analyses  30  nM  siRNA  3  was  used  to
suppress p62 expression (Figure 1). Total ubiquitin protein
conjugate  levels  were  accumulated  to  a  great  extent  in
response  to  MG-132  treatment.  However,  there  was  no
marked difference in total ubiquitin protein conjugate levels
between  MG-132  treated  cells  or  combined  MG-132
treatment with p62 mRNA silencing.
Since p62 is known to be a ubiquitin-binding protein, the
cells were treated with nonsilencing and silencing p62 siRNA
oligonucleotides, together with 5 µM MG-132 for 24 h and
then analyzed by immunofluorescence microscopy. The p62
depletion evoked a decrease in the perinuclear stainings of
p62, but also in the ubiquitin protein conjugation, as found
when analyzed by immunostaining (Figure 4). Note that no
change  in  the  total  ubiquitin  protein  conjugate  level  was
observed between MG-132 treated cells or combined MG-132
treatment with p62 mRNA silencing (Figure 1). This reveals
that p62 might regulate the localization of ubiquitin-conjugate
levels rather than affecting their total amount in proteasome
inhibitor–treated ARPE-19 cells.
The  HSP70  molecular  chaperone,  proteasomes,  and
autophagy have an important regulatory role in the protein
turnover of human RPE cells [13]. The role of p62 was studied
in perinuclear protein aggregation and autophagy clearance
by treating ARPE-19 cells with nonsilencing and silencing
siRNAs for hsp70 or p62. The cells were nonstressed, exposed
to 5 µM MG-132 for 24 h, or exposed to 5 µM MG-132 for
24 h and allowed to recover in normal cell culture medium up
to 48 h. The ultrastructure of the cells was examined using
transmission  electron  microscopy.  In  control  cells,  no
abnormalities  were  observed,  whereas  MG-132  evoked  a
prominent  perinuclear  deposit  accumulation,  as  expected
(Figure  5A).  We  have  previously  demonstrated  that  the
accumulated material is lysosomal LAMP-1 and LAMP-2
positive [13]. Both hsp70 and p62 depletion evoked similar
autophagy-like structures in perinuclear space in response to
the proteasome inhibition; this was followed by a recovery in
normal cell culture medium (Figure 5B).
The localization of pDsRed2-hp62 and pEGFP-HSP70
was studied by exposing ARPE-19 cultures to 5 µM MG-132
for 24 h and then allowing them to recover for either 24 or 48
h.  The  pDsRed2-hp62  and  pEGFP-hHSP70  constructs
showed  that  both  p62  and  HSP70  proteins  were  strongly
colocalized  to  the  same  area  in  perinuclear  deposits  after
proteasome inhibition (Figure 6).
The p62 and hsp70 RNA interference effects on LC3
levels, as an indicator of autophagy dynamics, were analyzed
by western blotting. ARPE-19 cells were exposed to 50 nM
bafilomycin  simultaneously  with  nonsilencing  siRNA,
hsp70 siRNA, or p62 siRNA for 24 h. The silencing of p62
mRNA decreased LC3-II accumulation and the ratio of LC3-
II/I, while hsp70 siRNA did not markedly affect the LC3-II
levels (Figure 7).
Our recent findings reveal that bafilomycin is a stronger
autophagy  inducer  than  MG-132  in  ARPE-19  cells  [13];
therefore, we also wanted to study the effects of bafilomycin
Figure 7. Western blotting analysis for evaluating the effects of
p62 or hsp70 RNA interference on LC3 levels in ARPE-19 cells
treated with bafilomycin. A: The cells were exposed simultaneously
to 50 nM bafilomycin and the transfection reagent, nonsilencing
RNA, hsp70 siRNA, or p62 siRNA for 24 h. The untreated control
is represented by 0, while tr. stands for transfection reagent, negative
for nonsilencing siRNA, hsp70, and p62 for silencing siRNAs. α-
tubulin staining was used to ensure equal loading of proteins. B:
Normalization against α-tubulin. C: The ratio of a lipidated LC3-II
to a nonlipidated LC3-I. Experiments were repeated two independent
times.
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1407in  proteasome  inhibitor–treated  ARPE-19  cells.  The  cells
were  exposed  to  5  µM  MG-132  simultaneously  with
nonsilencing siRNA, p62 siRNA, or hsp70 siRNA for 24 h,
and then allowing the cells to recover in normal cell culture
medium or in 50 nM bafilomycin for 24 h. Bafilomycin clearly
increased the LC3-II/I ratio in proteasome inhibitor–treated
cells. Only a mild effect of LC3-II levels was observed in
response to pure MG-132 exposure. Neither p62 nor hsp70
siRNA  decreased  the  LC3-II/I  ratio  in  cells  exposed  to
proteasome inhibition (Figure 8). This reveals that in certain
concentrations,  proteasome  inhibitor–induced  autophagy
might be independent of the p62 protein.
In addition to LC3, it is also possible to use p62/SQSTM1
as an autophagy marker [35]. The p62 protein serves as a link
between  LC3  and  ubiquitinated  substrates;  p62  becomes
incorporated  into  the  completed  autophagosome  and  is
degraded in autolysosomes. Therefore, ARPE-19 cells were
exposed to 5 µM MG-132 simultaneously with nonsilencing
siRNA, p62 siRNA, or hsp70 siRNA for 24 h, and then the
cells were allowed to recover in normal cell culture medium
or 50 nM bafilomycin for either 6 or 24 h. When the cells were
exposed  to  bafilomycin,  a  clear  p62  accumulation  was
observed in western blots (Figure 9). This indicates autophagy
clearance for p62 in proteasome inhibitor –treated ARPE-19
cells.  Taken  together,  our  findings  reveal  that  there  is  a
threshold level for p62 to regulate autophagy in ARPE-19
cells.  The  p62-dependent  autophagy  occurs  in  a  strong
bafilomycin-induced  response,  while  a  weaker  autophagy
induction after proteasome inhibition might be independent
of p62.
We  have  recently  shown  [13]  that  HSP70  has  a
cytoprotective capacity in response to proteasome inhibition.
In the present experiments, we wanted to compare the effect
of  p62  to  HSP70.  Thus,  we  treated  the  cells  with  5  µM
MG-132, subjected them to p62 or hsp70 mRNA silencing for
24 h, and then allowed them to recover in normal cell culture
medium up to 72 h. The MTT cell viability analysis (Figure
10) showed that there is evidence of a similar cytoprotective
capacity between p62 and HSP70 in proteasome inhibitor–
treated ARPE-19 cells.
DISCUSSION
We  have  recently  shown  that  HSP70,  proteasomes,  and
autophagy  work  together  to  regulate  protein  turnover  in
human RPE cells [13]. In this study, we demonstrate that the
proteasome  inhibitor  MG-132  evoked  a  strong  time-  and
concentration-related  accumulation  of  p62  in  perinuclear
lysosomal vesicles/residual bodies. Interestingly, pDsRed2-
hp62  and  pEGFP-hHSP70  confocal  microscopy  analyses
revealed  strong  colocalization  of  p62  and  HSP70  in  the
perinuclear protein aggregates after proteasome inhibition. A
comparison of the p62 mRNA and hsp70 mRNA depletion
indicates that both proteins have similar cytoprotective effects
in response to proteasome inhibition in ARPE-19 cells. In
contrast, the silencing of p62 mRNA, but not hsp70, reduced
LC3-II expression with treatment with the macroautophagy
inhibitor bafilomycin. In addition, the silencing of p62 mRNA
changed ubiquitin protein conjugate localization, but did not
affect  total  ubiquitin  protein  levels  after  proteasome
inhibition.  Based  on  our  previous  [13]  and  the  present
findings, we believe that both p62 and HSP70 are crucial
molecules in the regulation of autophagy-linked proteolysis
and cell viability in human RPE cells, but they have different
functions in these cellular processes and are not regulated by
each other.
The  p62  was  found  in  polyubiquitinated  protein
aggregates  in  response  to  proteasomal  depletion  [22].
Subsequently, it has been observed that p62 is expressed in
many  neurodegenerative  diseases  such  as  in  Parkinson,
Alzheimer, and Huntington’s diseases [23-26]. Interestingly,
several  proteins  identified  in  the  deposits  occurring  in
Alzheimer  disease  have  also  been  found  in  eye  samples
isolated from patients with AMD [36]. The p62 protein is one
of  the  main  molecules  controlling  the  shuttling  of
ubiquitinated substrates to the proteasomal degradation [20,
27]. At present, there is emerging evidence that the p62-
ubiquitin-substrate protein complexes are being targeted to
autophagic degradation [31,37]. In this paper, we demonstrate
that increased accumulation of perinuclear aggregates and p62
are concentration- and time-dependent on MG-132 loading.
We observed mild accumulation of LC3-II, which reveals
autophagosomal activity, in response to proteasome inhibitor
treatment in ARPE-19 cells. However, there was no difference
in LC3-II levels after simultaneous treatment with proteasome
inhibitor and p62 or hsp70 siRNA when compared to pure
proteasome inhibitor–treated cells. However, when the cells
were exposed to the macroautophagy inhibitor bafilomycin,
the silencing of p62 decreased LC3-II levels. In addition,
bafilomycin increased p62 accumulation under proteasome
inhibition. This relates to the suppression of autophagy. It
seems that macroautophagy is a master clearance system to
remove proteasome inhibitor–induced perinuclear cargo, but
there  might  be  a  threshold  level  for  the  p62-dependent
autophagy induction. The p62 protein seems to regulate the
localization  of  ubiquitinated  proteins,  since  we  observed
decreased perinuclear accumulation of ubiquitinated proteins
in response to p62 silencing and proteasome inhibition in the
RPE cells. However, total ubiquitin levels were not changed
in these treatments. A previous study demonstrated that p62
depletion evoked decreased ubiquitination and proteasomal
protein degradation [20]. We propose that autophagy is a
selective and compensatory clearance system for proteasomes
in  RPE  cells,  as  has  been  recently  discussed  [9,28].  In
addition, p62 seems to be an important regulatory protein in
the  other  direction  toward  proteasomal  pathways,  since
reduced  autophagic  activity  leads  to  the  accumulation  of
proteasome substrates and this is predominantly regulated by
p62 [16]. There is increasing evidence that both p62 and
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1408ubiquitin  are  required  for  effective  protein  clearance  via
proteasomes and autophagy in RPE cells. However, lack of
autophagy may lead to the accumulation of p62, which is not
good for cells, as it induces a cellular stress response that
evokes potentiated cellular damage [38].
All cells and tissues are challenged by different kinds of
stresses that vary in their severities and durations. The RPE
cells are exposed to chronic oxidative stress; since they are
under  constant  light  stimuli,  they  consume  high  levels  of
oxygen and are exposed to the high levels of lipid peroxidation
derived from the photoreceptor outer segments. The presence
of these stress stimuli means that macromolecules such as
proteins are continuously exposed to potential damage that
can cause loss of molecular function and depletion of RPE cell
populations  during  aging.  One  of  the  most  important
homeostatic responses involved in maintaining longevity is
the induction of heat shock proteins (HSP) to repair damaged
intracellular proteins [1,39,40]. Aging and tissue degeneration
involve  the  accumulation  of  damage  in  cellular
macromolecules in postmitotic cells such as RPE cells. It has
been proposed recently that increased protein damage during
aging may be exacerbated by a declining heat shock response,
Figure 8. Analysis of LC3 expression levels. A: western blotting analysis for evaluating the effects of p62 or hsp70 RNA interference on LC3
levels in ARPE-19 cells treated with 5 µM MG-132 and 50 nM bafilomycin. Lane 1. control medium for 36 h; lane 2. MG-132 for 24 h +
recover 6 h; lane 3. control medium for 24 h + bafilomycin for 6 h; lane 4. MG-132 + nonsilencing RNA for 24 h + recover 6 h; lane 5. MG-132
+ p62 siRNA for 24 h + recover 6 h; lane 6. MG-132 + hsp70 siRNA for 24 h + recover 6 h; lane 7. MG-132 + nonsilencing RNA for 24 h +
recover in bafilomycin for 6 h; lane 8. MG-132 + p62 siRNA for 24 h + recover in bafilomycin for 6 h; lane 9. MG-132 + hsp70 siRNA for
24 h + recover in bafilomycin for 6 h; lane 10. control medium for 48 h; lane 11. MG-132 for 24 h + recover 24 h; lane 12. control medium
for 24 h + bafilomycin for 24 h; lane 13. MG-132 + nonsilencing RNA for 24 h + recover 24 h; lane 14. MG-132 + p62 siRNA for 24 h +
recover 24 h; lane 15. MG-132 + hsp70 siRNA for 24 h + recover 24 h; lane 16. MG-132 + nonsilencing RNA for 24 h + recover in bafilomycin
for 24 h; lane 17. MG-132 + p62 siRNA for 24 h + recover in bafilomycin for 24 h; lane 18. MG-132 + hsp70 siRNA for 24 h + recover in
bafilomycin for 24 h. α-tubulin staining was used to ensure equal loading of proteins. B: The ratio of a lipidated LC3-II to a nonlipidated LC3-
I. Experiments were repeated two independent times.
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1409reduced  levels  of  HSPs,  and  the  resultant  loss  of  protein
quality control [39]. Consequently, sensors such as HSPs that
detect  different  forms  of  stress  have  evolved  to  promote
cellular adaptation and survival. The expression of HSPs is
induced in response to a variety of chemical and physical
stresses to prevent protein damage and detrimental protein
aggregation [1,13,41,42].
In addition to these crucial homeostatic functions, recent
findings have indicated that HSP70, together with ferritin and
metallothionein,  chelates  lysosomal  iron  in  a  non-redox-
active form that triggers autophagy clearance [43]. We have
demonstrated that oxidative stress strongly induces HSP70
expression  in  RPE  cells  [5,44].  There  is  speculation  that
oxidative stress may increases permeabilization of lysosomes
because of their content of redox-active iron and that may be
one reason for the upregulation of the HSPs [45]. HSP70 has
been shown to localize within lysosomes and to possess a
capacity to depress lysosomal redox-active iron, as well as to
modify the permeabilization of lysosomes [13,42,45,46]. In
this work, we have demonstrated that p62 strongly colocalizes
with  proteasome  inhibitor–induced  perinuclear  deposits.
There is also strong colocalization between p62 and HSP70.
Proteasome  inhibitor–induced  perinuclear  deposits  are
targeted to macroautophagy. We suppose that p62, rather than
Figure 9. Analysis of p62 expression levels. A: western blotting analysis for evaluating the effects of p62 or hsp70 RNA interference on p62
levels in ARPE-19 cells treated with 5 µM MG-132 and 50 nM bafilomycin. Lane 1. control medium for 36 h; lane 2. MG-132 for 24 h +
recover 6 h; lane 3. control medium for 24 h + bafilomycin for 6 h; lane 4. MG-132 + nonsilencing RNA for 24 h + recover 6 h; lane 5. MG-132
+ p62 siRNA for 24 h + recover 6 h; lane 6. MG-132 + hsp70 siRNA for 24 h + recover 6 h; lane 7. MG-132 + nonsilencing RNA for 24 h +
recover in bafilomycin for 6 h; lane 8. MG-132 + p62 siRNA for 24 h + recover in bafilomycin for 6 h; lane 9. MG-132 + hsp70 siRNA for
24 h + recover in bafilomycin for 6 h; lane 10. control medium for 48 h; lane 11. MG-132 for 24 h + recover 24 h; lane 12. control medium
for 24 h + bafilomycin for 24 h; lane 13. MG-132 + nonsilencing RNA for 24 h + recover 24 h; lane 14. MG-132 + p62 siRNA for 24 h +
recover 24 h; lane 15. MG-132 + hsp70 siRNA for 24 h + recover 24 h; lane 16. MG-132 + nonsilencing RNA for 24 h + recover in bafilomycin
for 24 h; lane 17. MG-132 + p62 siRNA for 24 h + recover in bafilomycin for 24 h; lane 18. MG-132 + hsp70 siRNA for 24 h + recover in
bafilomycin for 24 h. α-tubulin staining was used to ensure equal loading of proteins. B: Normalization against α-tubulin levels.
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1410HSP70, regulates autophagic activity when studied by the
RNA silencing technique. Obviously, HSP70 tries to refold
damaged protein, leading to improved vitality in response to
proteasome  inhibition;  however,  if  this  process  is  not
successful, then the proteins are aggregated and targeted to
macroautophagic clearance.
Autophagy is attributable to the turnover of damaged
cellular  components  in  response  to  age-related  cellular
modifications such as starvation, hypoxia, and oxidative stress
[1,2]. At present, it is known that autophagic degradation is
involved in several human neurodegenerative diseases [14].
Interestingly, it has been demonstrated that in human AMD
donor samples there are accumulations of autophagic markers
and  decreased  lysosomal  activity  [6,7].  An  effective
autophagic  clearance  system  has  also  recently  been
documented in human RPE cells [4,5,7,13]. During aging,
lipofuscin accumulates in lysosomes, revealing a decreased
cellular  capacity  to  degrade  proteins  [47].  In  addition,
lipofuscin promotes the misfolding of intracellular proteins,
which evokes additional oxidative stress in RPE cells [48,
49]. Once lysosomes are inhibited by bafilomycin, intense
autophagosome formation can be observed that coincides with
LC3-II  accumulation  in  ARPE-19  cells.  If  the  lysosomal
function is suppressed with bafilomycin, macroautophagic
clearance is not triggered and proteasome inhibitor–induced
protein aggregates are retained in the RPE cell cytoplasm
[13]. This might provide a simple chemical model to study
lysosomal clearance mechanisms in RPE cells and may help
unravel the pathogenesis of AMD, since preservation of the
autophagic activity is associated with a lower intracellular
accumulation of damaged proteins, better ability to handle
protein  damage,  improvement  in  tissue  function,  and
retardation of the aging process [14].
Our  findings  reveal  that  p62  and  HSP70  colocalize
strongly in response to proteasome inhibition. Both HSP70
and p62 play central roles in improving cellular viability when
proteasomal pathways are disturbed in RPE cells. However,
it  seems  that  p62  but  not  HSP70  can  regulate  LC3
accumulation  in  conditions  when  lysosomes  and
macroautophagy  are  inhibited.  In  proteasome  inhibitor–
treated RPE cells, the perinuclear protein aggregates undergo
effective  autophagic  clearance.  These  findings  open  new
avenues  for  understanding  the  mechanisms  of  proteolytic
processes  in  retinal  cells,  and  could  be  useful  in  the
development of novel therapies targeting p62 and HSP70
[50-52],  or  the  proteins  that  regulate  lysosomal-mediated
proteolysis [52,53], with the aim of preventing retinal cell
deterioration during aging such as that occurring in AMD
[1].
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